Tagged with R

Zentiva The GM of one of the leading generics companies on the Romanian market shares insights into why generics penetration remains underdeveloped and the importance of having an export strategy and diversified portfolio.   You have been in your current position since 2009, witnessing many changes. Can you introduce Zentiva in…

clinical trials The president of the association representing clinical research organisations speaks out about Romania’s attractiveness as a destination country in an era of clinical research globalisation. He further sheds ideas on fostering greater in-country R&D activity and outlines his personal vision for developing the association. How did the association come into…

distribution Bomi Peru was incorporated in January 2014, amidst a number of new openings of the Italian logistics company. Andres Vazquez, commercial director, traces the evolution of the affiliate over the last year and his plan to expand in this competitive marketplace. You joined a little over year ago. What initial…

innovation Induquímica is the only Peruvian pharmaceutical company with the “Marca Peru” emblem, a result of the company’s extremely high quality. General Manager Christian Quintanilla talks about the company’s success, and their unique strategy of relying on their reputation instead of using medical reps to sell their products. In what context…

hospitals Luis Pinillos and Carlos Vallejos both served as Directors of INEN, the Cancer Institute and Minister of Health during President Garcia’s administrations. They discuss the achievements made before, during and after their terms, as well as the exciting new developments being made with the Grupo Auna, as a leading network…

Hospira Carolina López-Torres joined Hospira Peru in 2011 following a dynamic career at Novartis. She discusses the early challenges she faced and the opportunities that the government’s hospital expansion plan has provided the market leader for pumps in Peru. What was the initial mission given to you when you first arrived?…

cancer Eduardo Payet of INEN outlines the institution’s agenda for preventing advanced stages of cancer and plans to expand oncology services beyond Lima to more remote regions of Peru. What is your assessment of the state of cancer in Peru today? Peru is experiencing a demographic and epidemiological transition as a…

MSD Guillermo Browne, Managing Director of MSD Peru, talks about the turnover of the affiliate and the company’s success in bringing new innovation to the country, particularly in the areas of vaccines and oncology. You arrived in Peru in January 2014. What initial tasks did you set for yourself? When I arrived, MSD…

access The president of Turkey’s social security institution, the SGK, discusses the evolution of healthcare spending over the past three years, and the underpinning principles guiding their drug reimbursement policy decisions. Since 2012, medical expenses have been increasing; can you please analyze the situation? Since 2006, the ‘Sosyal Güvenlik Kurumu’ (SGK),…

exports The chairman and general manager of Bottu discuss their flagship product, Doliprane, the potential for export to the rest of Africa, and partnerships with European labs. Bottu is a Moroccan laboratory and is a little over sixty years old. The company experienced a dramatic acceleration in business a few years…

export The CEO of one of Morocco’s largest pharma companies discusses investment in production capacity, and the potential to export products to French and English-speaking Africa.    Can you introduce Pharma 5 and its organization in a few words? The Pharma 5 group, a Moroccan pioneer in generic drug development and…

manufacturing The director general of Cooper Pharma explains how the company has become the leading Moroccan player, why Morocco´s relationship with Africa is one of cooperation not exploitation, and how the country now needs to look towards innovation if it is to compete.   Cooper Pharma celebrated its 80th anniversary in…